Skip to content
Open access

Spreading alpha-synuclein oligomers trigger astrocyte/microglial changes and astrocyte-glutamatergic neuron system dysfunction in an age-related manner

Sep 2026 · Molecular Neurodegeneration Advances · Vol 2 · 0 citations · 113 references

TL;DR

A model in which α-syn oligomer spreading, amplified by aging, simultaneously disrupts the astrocyte–glutamatergic neuron axis and drives microglia into a senescent DAM-like state is proposed, and candidate gene sets for both processes are provided for further investigation of glial dysfunction in PD.

Abstract

Parkinson’s disease (PD) is characterized by the progressive accumulation and spatio-temporal spread of α-synuclein (α-syn) oligomers and a progressive loss of dopaminergic neurons. Many studies showed a direct cytotoxic effect of α-syn oligomers on neurons. Other cell types including astrocytes or microglia were also reported to show specific responses to α-syn and are believed to play a role in the spreading of PD pathology. To investigate the transcriptional and cellular consequences of α-syn oligomer spreading, we employed spatial transcriptomics, single-nucleus RNA sequencing (snRNA-seq), and bulk RNA sequencing (bRNA) of isolated microglia in a transgenic PD mouse model expressing human α-syn in neurons. We further compared our findings to published public snRNA-seq datasets from human PD patients. Our analysis identified a transcriptional “Spreading Signature” associated with α-syn pathology in the substantia nigra in our PD mouse model. We found an age correlated increase in astrocytes, close interactions between astrocytes and α-syn, and transcriptional dysregulation of the astrocyte-glutamatergic neuron axis. We further identified two subtypes of glutamatergic neurons that are vulnerable to astrocytic changes. The surviving microglial population shifted towards a senescent, disease-associated microglia (DAM)-like state with enhanced phagocytic, lysosomal, and motile signatures, and the accumulation of swollen lysosomal pockets. Astrocytic and microglial changes, including diminished neuronal signaling, were partly concordant between mouse and human SN datasets. Based on our results, we propose a model in which α-syn oligomer spreading, amplified by aging, simultaneously disrupts the astrocyte–glutamatergic neuron axis and drives microglia into a senescent DAM-like state, and we provide candidate gene sets for both processes for further investigation of glial dysfunction in PD.

Read PDF

Similar papers

Open access Sep 2026

Cellular prion protein levels modulate nigrostriatal vulnerability to α-synuclein oligomers in Parkinson’s disease

α-Synuclein oligomer (αSynO)-mediated neurodegeneration is a hallmark of Parkinson’s disease (PD) pathogenesis, yet the molecular mechanisms mediating this toxicity remain elusive. In this study, we investigated the cellular prion protein (PrPC) as a key modulator of αSynO-induced neurodegeneration using an integrative...

Flavio de Souza Júnyor, F. Leser, Sarah de Souza Albuquerque et al. · 0 citations
Open access Oct 2026

Astrocytic cathepsin D promotes α-synuclein processing and Lewy neurite-like aggregate maturation.

Parkinson's disease (PD) and related synucleinopathies are marked by the accumulation and propagation of α-synuclein (α-syn) aggregates, a process primarily studied in neurons. Whether astrocytes actively contribute to α-syn processing and intercellular transfer remains unclear. Here, using a physiologically relevant n...

Hiroshi Hanafusa, Kota Ohashi, Hiromu Shojima et al. · 0 citations
Open access Aug 2026

Multiple system atrophy-derived α-synuclein fibrils are more potent and display oligodendrocyte cell tropism compared to Parkinson's disease-derived fibrils.

Interestingly, amplified material from MSA brains induced significantly more oligodendroglial pSyn aggregates than amplified material from PD brains, and mice injected with the fibril polymorph, showed mild changes in microglial reactivity.

Anne-Line Strange Laursen, K. Willén, Alexis Fenyi et al. · 0 citations
Review 2026

Glial control of extracellular α-synuclein propagation in LRRK2 Parkinson's disease.

This review synthesises current evidence on how mutations in Leucine-Rich Repeat Kinase 2 (LRRK2), the most common genetic cause of familial PD, fundamentally corrupt glial handling of extracellular α-synuclein and evaluates emerging therapeutic strategies targeting LRRK2 kinase activity, NLRP3 inflammasome activation,...

Indrani Datta, Dibyam Debasish Sahu · 0 citations
Oct 2026

Human microglia clear intraneuronal α-synuclein aggregates by GPNMB-mediated trogocytosis.

Microglia are the primary immune cells of the brain, but their role in Parkinson's disease is not fully understood. Chronic microglial activation is toxic to neurons, but in the early stages of pathology, microglia also exert beneficial functions. We used induced pluripotent stem cell (iPSC)-derived coculture models to...

Hung-Ju Chueh, Antigoni Katsikoudi, Ana Aragón-González et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.